Skip to content

External Coverage

Aussie biotech ASX:NXN tackling preventable newborn infections with world-first diagnostic tech

Jane Morgan Management13 October 2025

Jane Morgan Management profiles Nexsen's world-first diagnostic technology, focused on rapid Group B Streptococcus testing and the broader commercial potential of its nano-biotechnology pla...

Overview

Jane Morgan Management profiles Nexsen's world-first diagnostic technology, focused on rapid Group B Streptococcus testing and the broader commercial potential of its nano-biotechnology pla...

Source: Jane Morgan Management